Document Detail

The NAD metabolome - a key determinant of cancer cell biology.
MedLine Citation:
PMID:  23018234     Owner:  NLM     Status:  Publisher    
NAD is a vital molecule in all organisms. It is a key component of both energy and signal transduction - processes that undergo crucial changes in cancer cells. NAD(+)-dependent signalling pathways are many and varied, and they regulate fundamental events such as transcription, DNA repair, cell cycle progression, apoptosis and metabolism. Many of these processes have been linked to cancer development. Given that NAD(+)-dependent signalling reactions involve the degradation of the molecule, permanent nucleotide resynthesis through different biosynthetic pathways is crucial for incessant cancer cell proliferation. This necessity supports the targeting of NAD metabolism as a new therapeutic concept for cancer treatment.
Alberto Chiarugi; Christian Dölle; Roberta Felici; Mathias Ziegler
Related Documents :
23924944 - The role of thyroid hormone signaling in the prevention of digestive system cancers.
23562214 - Molecular determinants of trastuzumab efficacy: what is their clinical relevance?
24886294 - Par2-mediated upregulation of bdnf contributes to central sensitization in bone cancer ...
24862854 - Canoncial and non-canonical hedgehog signalling and the control of metabolism.
25410964 - Eph family co-expression patterns define unique clusters predictive of cancer phenotype.
15613014 - Increased incidence of neoplasia of the digestive tract in men with persistent activati...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-28
Journal Detail:
Title:  Nature reviews. Cancer     Volume:  -     ISSN:  1474-1768     ISO Abbreviation:  Nat. Rev. Cancer     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101124168     Medline TA:  Nat Rev Cancer     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Preclinical and Clinical Pharmacology, University of Firenze, 50139, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clopidogrel Two Doses Comparative 1-Year Assessment of Safety and Efficacy (COMPASS) Study in Japane...
Next Document:  Advances in Osteoimmunology: Pathophysiologic Concepts and Treatment Opportunities.